Burch P - Search Results

1

Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.

O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE. O'Connell MJ, et al. Among authors: burch p. J Clin Oncol. 1998 Jul;16(7):2528-33. doi: 10.1200/JCO.1998.16.7.2528. J Clin Oncol. 1998. PMID: 9667274 Clinical Trial.

2

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.

Burch PA, Mailliard JA, Hillman DW, Perez EA, Krook JE, Rowland KM, Veeder MH, Cannon MW, Ingle JN. Burch PA, et al. Am J Clin Oncol. 2005 Apr;28(2):195-200. doi: 10.1097/01.coc.0000144815.54746.d0. Am J Clin Oncol. 2005. PMID: 15803016 Clinical Trial.

3

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma.

Rubin J, Gallagher JG, Schroeder G, Schutt AJ, Dalton RJ, Kugler JW, Morton RF, Mailliard JA, Burch PA. Rubin J, et al. Among authors: burch pa. Cancer. 1996 Nov 1;78(9):1888-91. doi: 10.1002/(sici)1097-0142(19961101)78:9<1888::aid-cncr7>3.0.co;2-b. Cancer. 1996. PMID: 8909307 Clinical Trial.

4

Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.

Galanis E, Buckner JC, Burch PA, Schaefer PL, Dinapoli RP, Novotny PJ, Scheithauer BW, Rowland KM, Vukov AM, Mailliard JA, Morton RF. Galanis E, et al. Among authors: burch pa. J Clin Oncol. 1998 Sep;16(9):2953-8. doi: 10.1200/JCO.1998.16.9.2953. J Clin Oncol. 1998. PMID: 9738563 Clinical Trial.

5

Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.

Martenson JA, Shanahan TG, O'Connell MJ, Cobau CD, Schroeder G, Burch PA, Levitt R, Rowland KM Jr. Martenson JA, et al. Among authors: burch pa. Cancer. 1999 Aug 15;86(4):710-4. doi: 10.1002/(sici)1097-0142(19990815)86:4<710::aid-cncr21>3.0.co;2-5. Cancer. 1999. PMID: 10440700 Clinical Trial.

6

North Central Cancer Treatment Group Phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survival as the primary endpoint of efficacy.

Burch PA, Keppen MD, Schroeder G, Rubin J, Krook JE, Dalton RJ, Gerstner JB, Jancewicz MT, Ebbert LP. Burch PA, et al. Am J Clin Oncol. 1999 Oct;22(5):505-8. doi: 10.1097/00000421-199910000-00017. Am J Clin Oncol. 1999. PMID: 10521068 Clinical Trial.

7

Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.

Burch PA, Block M, Schroeder G, Kugler JW, Sargent DJ, Braich TA, Mailliard JA, Michalak JC, Hatfield AK, Wright K, Kuross SA. Burch PA, et al. Clin Cancer Res. 2000 Sep;6(9):3486-92. Clin Cancer Res. 2000. PMID: 10999733 Clinical Trial.

8

Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.

Burch PA, Ghosh C, Schroeder G, Allmer C, Woodhouse CL, Goldberg RM, Addo F, Bernath AM, Tschetter LK, Windschitl HE, Cobau CD. Burch PA, et al. Am J Clin Oncol. 2000 Oct;23(5):534-7. doi: 10.1097/00000421-200010000-00021. Am J Clin Oncol. 2000. PMID: 11039519 Clinical Trial.

9

Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group.

Moertel CG, Gunderson LL, Mailliard JA, McKenna PJ, Martenson JA Jr, Burch PA, Cha SS. Moertel CG, et al. Among authors: burch pa. J Clin Oncol. 1994 Jan;12(1):21-7. doi: 10.1200/JCO.1994.12.1.21. J Clin Oncol. 1994. PMID: 8270979

10

Future role of radiotherapy as a component of treatment in biliopancreatic cancers.

Gunderson LL, Haddock MG, Burch P, Nagorney D, Foo ML, Todoroki T. Gunderson LL, et al. Among authors: burch p. Ann Oncol. 1999;10 Suppl 4:291-5. Ann Oncol. 1999. PMID: 10436843 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page